Mativ Holdings, Inc. (MATV) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

73OpportunityDD: Sep 08, 2026Analyst: 72

paidPrice at analysis date

USD 12.5 (08/09/2026)

domainMkt cap

$684.59M

pie_chartShares

54.68M

candlestick_chart52W

$7.07-$15.48

trending_downShort interest

7.7%

INFONYSEMaterials5900 employees

Verdict: Favorable Risk/Reward —

Post-merger integration inflection point. Q2 2026 delivered the highest quarterly adjusted EBITDA ($75M) since Mativ's formation, with SAS segment margins expanding 210bps to 15.3% and free cash flow reaching $60M in a single quarter. Debt refinancing pushed nearest maturity out beyond 3 years, and management targets 2.5–3.5x net leverage by mid-2027 (vs. 3.8x today). Forward EV/EBITDA of ~6.1x sits at a 27% discount to the specialty materials/packaging peer median (~8.4x) despite double-digit EBITDA growth. Near-term Q3 headwind from Wisconsin tornado ($20–25M revenue impact) already disclosed and largely priced in. Asymmetric setup: capped downside on private-market EV floor, credible re-rating path as deleveraging tracks and margin expansion confirms.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-09-08

Mativ Holdings, Inc. (MATV)

Specialty Papers & Adhesives · NYSE · Alpharetta, GA

"Post-merger turnaround: record margins, refinanced debt, structural discount to peers."

Q2 record EBITDA $75M FCF $60M in one quarter EV/EBITDA fwd 6.1x Net leverage 3.8x Q3 tornado headwind

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value estimate — EV/Adjusted EBITDA (peer-derived, leverage-adjusted)

Fair value base case

USD 18.9

Range: USD 10.0-USD 25.0

Price at analysis date: USD 12.5 (08/09/2026)

Base upside/downside: +51%

Sum-of-parts EV/EBITDA on FY27E segment-level EBITDA with peer-derived multiples (SAS 7.5x, FAM 8.0x — filtration commands premium), less corporate drag and net debt. Cross-check with P/Sales 0.55x gives $20.60/sh, within +9% of base. Sensitivity: ±1x EBITDA multiple = ±$5.0/sh; ±$20M FY27E EBITDA = ±$2.6/sh. Weighted average expected value: 0.25×$24 + 0.50×$19 + 0.25×$10 = $18.00. Base case $18.90 sits between weighted expected value and analyst PT of $21. ⚠️ Not investment advice.

Component	Assumption	USD/share
SAS segment EV (Sustainable & Adhesive Solutions)	$200M FY27E EBITDA (Q2 $50M × 4) × 7.5x = $1,500M EV / 54.68M sh	+27.43
FAM segment EV (Filtration & Advanced Materials)	$135M FY27E EBITDA (Q2 $35M × 4 − $5M tornado) × 8.0x = $1,080M EV	+19.75
Corporate cost drag (unallocated)	−$60M/yr corporate overhead × 7.5x = −$450M EV	−8.23
Net debt (Q2 2026 balance)	$974.5M debt − $66.3M cash = $908.2M net debt / 54.68M sh	−16.61
Wisconsin tornado one-time provision	Q3 $20–25M rev impact + repair costs = ~$35M pre-tax net drag / 54.68M	−0.64
Deleveraging option value	50% prob × 1.0x multiple expansion on $275M EBITDA if leverage < 3.0x by 2027 = +$137M EV / 54.68M	+1.26
SBC dilution drag (annualized)	~1.2% net dilution × 3 yrs × $18.90 base FV = haircut	−0.68
FV base case	Arithmetic sum of components above (rounding ±$0.10)	≈ $22.28 → $18.90 (risk-adj)

Bull

$23.00–$25.00

Probability: 25%

SAS margin expansion continues to 17%+, FAM stable at 17%+, FY27 EBITDA hits $310M+. Leverage falls to 2.5x by mid-2027. Multiple re-rates to peer median 8.5x. Strategic acquirer interest emerges given specialty portfolio + de-leveraged BS. Buyback initiated.

Base

USD 16.1-USD 21.7

Probability: 50%

Q3 2026 tornado impact absorbed as guided; Q4 rebounds. FY26 EBITDA lands $275–290M, FY27 $290–310M. Leverage tracks to 3.0x by mid-2027. Multiple re-rates modestly to 7.0–7.5x. Deleveraging story validates thesis.

Bear

$9.00–$11.00

Probability: 25%

Consumer demand weakens through Q4 2026, SAS pricing traction reverses. FY27 EBITDA drops to $220–240M. Leverage stays >3.5x, covenant risk resurfaces. Multiple stays at 5.5–6.0x. Stock retests 52W low ~$7 in near term but private-market EV floor holds around $9–10.

Methodology: Sum-of-parts EV/EBITDA on FY27E segment-level EBITDA with peer-derived multiples (SAS 7.5x, FAM 8.0x — filtration commands premium), less corporate drag and net debt. Cross-check with P/Sales 0.55x gives $20.60/sh, within +9% of base. Sensitivity: ±1x EBITDA multiple = ±$5.0/sh; ±$20M FY27E EBITDA = ±$2.6/sh. Weighted average expected value: 0.25×$24 + 0.50×$19 + 0.25×$10 = $18.00. Base case $18.90 sits between weighted expected value and analyst PT of $21. ⚠️ Not investment advice. Not investment advice.

⚠️ Methodology note: MATV is a leveraged specialty materials turnaround post SWM+Neenah merger integration. TTM GAAP net income was negative on restructuring / goodwill charges; valuation is therefore anchored on EV/Adjusted EBITDA using Q2 2026 annualized (tornado-adjusted) numbers, cross-checked against P/Sales vs specialty materials & packaging peers. Floor is private-market EV on trough EBITDA (not net cash — company carries $908M net debt).

📊 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~7.7%

~2.95M sh shorted of ~38.4M float (54.68M outstanding, ~30% closely held). Moderate level, up from 1.98M sh prior period. Days to cover ~5–6 days. Reflects skepticism on leverage/integration; not squeeze territory.

🟡 Share dilution (1Y)

+0.4%

Share count essentially flat at 54.68M (Q2 2026) vs ~54.45M a year prior. SBC absorbed via natural attrition. No active buyback program disclosed as of Q2 2026 — company prioritizing debt paydown.

🔵 Capital allocation

Deleverage

Priority = debt paydown to 2.5–3.5x by mid-2027. Refinanced capital structure Q1 2026, pushing nearest maturity out >3 years. Total liquidity $345.5M ($66.3M cash + $279.2M revolver). Buyback likely deferred until leverage target hit.

Short Interest — context

MATV — 7.7%

7.7%

Insider activity: routine Form 4 filings during 2026 — tax-withholding share dispositions upon RSU vesting (e.g. 5,499 sh director in July 2026). No pattern of concentrated executive selling and no insider transactions above $500K aggregate over the past 12 months. Board and executive team appears aligned with long-term deleveraging thesis. No class action, no short-seller report, no SEC investigation identified for the past 12 months.

$Financial analysis — FY 2023–2027E

Revenue (Q2 2026)

$531.8M

+1.7% organic YoY

Q2 Adj EBITDA

$75.0M

+12% YoY, 14.1% margin

Net Debt (Q2 end)

$908M

3.8x LTM EBITDA

Enterprise Value

~$1.59B

EV/EBITDA fwd 6.1x

Item	FY2023	FY2024	FY2025	FY2026E	Guidance 2027E
Revenue ($M)	2,050	1,988	1,994	~2,050	~2,120
Adjusted EBITDA ($M)	230	220	250	275–290	~305
Adj EBITDA margin (%)	11.2%	11.1%	12.5%	13.4–14.1%	~14.5%
Free Cash Flow ($M)	45	25	80	140–160	~180
Total Debt / Net Debt ($M)	1,120 / 1,055	1,090 / 1,020	1,010 / 940	975 / 900	~870 / ~800
Net leverage (x LTM EBITDA)	4.6x	4.6x	3.8x	3.2–3.4x	~2.6x

Note: Merger of SWM + Neenah closed 2022; 2023–2024 was integration & restructuring period. Margin inflection began H2 2025 as SAS pricing discipline flowed through. FY26 guidance implicit (management withheld formal guidance) is derived from Q2 run-rate less Wisconsin tornado Q3 impact ($20–25M revenue). FY27 assumes tornado recovery, continued SAS margin uplift, and stable FAM.

Quarterly dynamics — last 5 quarters
Metric	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue ($M)	525.4	498.7	478.2	492.0	531.8
Adj EBITDA ($M)	67.0	60.5	58.5	62.5	75.0
Adj EBITDA margin (%)	12.8%	12.1%	12.2%	12.7%	14.1%
Free Cash Flow ($M)	32	28	25	18	60
End-of-period cash ($M)	52	58	62	55	66.3

Financial position and deleveraging trajectory

Net leverage vs 2.5–3.5x target

3.8x → 3.0x

Adj EBITDA margin trajectory

14.1% Q2

Total liquidity

$345.5M

Nearest debt maturity

>3 yrs out

account_tree

Business model — Specialty Materials post-merger platform

From leveraged paper aggregation to specialty materials platform

Mativ was formed in July 2022 by the merger of Schweitzer-Mauduit (SWM) and Neenah Inc. — two century-old paper & specialty materials companies. The combined entity carried significant financial leverage (~4.6x net EBITDA) and faced overlapping cost structures. Under CEO Shruti Singhal (appointed 2024), the company has aggressively pruned SG&A, exited low-margin end markets, refinanced maturities out beyond 2028, and shifted portfolio mix toward specialty paper, filtration, healthcare and adhesive solutions. Q2 2026 marked the highest quarterly adjusted EBITDA since the merger — a validation of the strategic pivot. The company operates two reporting segments (SAS + FAM) with FAM (Filtration & Advanced Materials) commanding premium margins (~17%) driven by defensible qualification-driven positions.

SAS — Sustainable & Adhesive Solutions ~$1,300M FY27E (~62% rev) 🟢 ramping Q2 2026 record EBITDA $50M (+18% YoY), margin 15.3% (+210bps). Tapes & labels +10% Q2. Commercial print outperforming market decline. Key pricing power on specialty adhesive paper. Target: 17% steady-state margin. FAM — Filtration & Advanced Materials ~$770M FY27E (~37% rev) 🟢 stable premium Q2 2026 EBITDA $35M, margin 17.6% (+1% YoY). Filtration media, developed films, coating & converting, extruded mesh. Qualification-driven end markets (transport, healthcare, industrial). Lower cyclicality; defensible technology. Corporate & unallocated ~−$60M FY27E (drag) 🟡 optimizing Corporate overhead + unallocated restructuring. Actively rationalized under Singhal. Target: bring below $50M by 2027 as merger synergies complete. Q3 2026 impacted by Wisconsin tornado facility repair cost.

gavel

Legal, regulatory and risk analysis

Financial leverage 3.8x net

High

Net debt $908M vs $250M LTM adj EBITDA = 3.8x. Elevated vs peer avg (~2.5x). Even with refinanced maturities beyond 2028, interest expense of $37M H1 2026 near operating profit. Deleveraging thesis depends on FCF conversion.

Wisconsin tornado Q3 impact

Medium

Management disclosed $20–25M Q3 sales impact + repair costs following July 2026 tornado hitting a FAM facility. Estimated ~$5M EBITDA drag Q3. Insurance recovery expected in Q4/Q1 but timing uncertain.

Commercial print structural decline

Medium

A meaningful sub-segment of SAS is commercial print paper, in structural secular decline (−3 to −5%/yr industry-wide). Mativ has outperformed the market decline via pricing/mix, but revenue rollover cap persists as a headwind.

Cyclical raw material exposure

Medium

Input costs — pulp, energy, latex, resins — are cyclical. Q2 2026 benefited from moderating input costs. A reversal (e.g., energy shock) could compress the freshly-earned margin expansion by 100–200bps within 2 quarters.

Free cash flow inflection confirmed

Positive

Q2 2026 FCF $60M — the strongest since merger. Full-year FCF conversion on track to double vs 2024. FCF funds direct debt paydown, accelerating deleveraging vs the natural EBITDA growth-only path.

Refinanced debt maturity wall

Positive

Q1 2026 refinancing pushed nearest maturity beyond 2028+. Total liquidity $345.5M ($66M cash + $279M revolver). Covenant risk remote at current cash flow profile. Removes the "distressed" overhang that pressured multiples in 2023–2024.

Peer discount compression opportunity

Strategic

Trading at ~6.1x forward EV/EBITDA vs peer median ~8.4x. Compression to 7.5x on FY27E $305M EBITDA unlocks +$5–7/sh equity value. Historical precedent: post-merger integration completion typically drives 50–100% of the gap-close over 12–18 months.

Clean governance / no litigation

Positive

No active securities class action, no short-seller reports, no SEC enforcement identified as of the latest review. Insider activity limited to routine RSU tax withholding. Board and CEO Singhal appear aligned with the deleveraging + margin thesis.

Strengths

Record Q2 2026 EBITDA ($75M) — best since merger formation, +12% YoY on organic growth.

SAS margin expanded 210bps to 15.3% — pricing discipline flowing through, tapes & labels growing near +10%.

Refinanced capital structure — nearest maturity beyond 2028+, liquidity $345.5M.

FAM segment 17.6% margins — defensible qualification-driven positions, low cyclicality.

FCF inflection confirmed — Q2 $60M, on track to double 2024 full-year figure.

Weaknesses

Net leverage still 3.8x — above peer avg of 2.5x, limits capital allocation flexibility.

Interest expense $37M H1 2026 — near operating profit line, sensitive to rate environment.

Limited sell-side coverage (1 analyst formal) — low institutional visibility, illiquidity discount.

Commercial print sub-segment in structural decline — chronic revenue headwind.

No active buyback until leverage < 3.0x — capital returns deferred 12–18 months.

Opportunities

Peer multiple compression: gap to 8.4x median unlocks +$5–7/sh even at conservative execution.

Strategic M&A interest as leverage normalizes — specialty portfolio attractive to strategics (Amcor/Berry template).

FAM filtration expansion into healthcare/EV thermal markets — premium end markets with secular tailwind.

Buyback reactivation post 2027 could accelerate per-share re-rating on shrinking float.

Wisconsin tornado insurance recovery — potential Q4/Q1 EBITDA one-time bump.

Threats

Consumer demand weakness — cyclical exposure via SAS packaging & labels into consumer durables.

Raw material cost shock — pulp/energy/latex reversal could compress margins 100–200bps within 2 quarters.

Q3 2026 Wisconsin tornado — $20–25M rev impact confirmed, uncertainty on recovery timing.

Rising rates scenario — refinancing at higher spreads if leverage stays elevated at 2028+ maturity.

Multiple stays discounted if integration narrative fatigue persists — "value trap" risk if EBITDA growth stalls.

🟢 Bull case core points

Q2 2026 record EBITDA validates the post-merger turnaround thesis; margin expansion has legs.

Debt refinanced beyond 2028 + $345M liquidity remove the "distressed" overhang.

Trading at 6.1x fwd EV/EBITDA vs peer median 8.4x — a 27% discount to a fresh margin-inflection story.

FCF conversion doubling; deleveraging path credible to 2.5–3.0x by mid-2027.

🔴 Bear case core points

Net debt $908M still 3.8x LTM EBITDA — any macro slowdown hits equity first, not enterprise.

Q3 2026 tornado headwind + potential Q4 consumer softness could stall momentum narrative.

Interest expense near operating profit line — refi at higher spreads is a real 2028 risk.

Multiple may stay discounted if next 2 quarters don't show sustained margin uplift.

🔵 Investor monitoring points

Q3 2026 earnings (~Nov 2026) — tornado impact vs guidance, Q4 outlook.

Net leverage ratio trajectory quarter-by-quarter (target <3.3x by year-end).

SAS margin quarter-over-quarter (needs to hold 14%+ to confirm structural shift).

Any capital return / buyback announcement — signal of confidence in cash generation.

{ "verdict_label": {"it": "Giudizio: Risk/Reward Favorevole", "en": "Verdict: Favorable Risk/Reward"}, "verdict_text": {"it": "MATV in inflection point post-merger. Q2 2026 EBITDA record $75M, FCF $60M, debito refinanziato oltre 2028. Multiplo 6.1x fwd vs peer 8.4x: sconto del 27% ingiustificato. Fair value base $18.90 (+51%).", "en": "MATV at post-merger inflection point. Q2 2026 record EBITDA $75M, FCF $60M, debt refinanced beyond 2028. Trades at 6.1x fwd vs peer 8.4x: unjustified 27% discount. Base FV $18.90 (+51%)."}, "bull_points": [ {"it": "Q2 2026 EBITDA record $75M, margine SAS +210bps a 15.3%: turnaround validato.", "en": "Q2 2026 record EBITDA $75M, SAS margin +210bps to 15.3%: turnaround validated."}, {"it": "Debito refinanziato oltre 2028, $345M liquidità: rimosso il rischio distress che comprimeva il multiplo.", "en": "Debt refinanced beyond 2028, $345M liquidity: distress overhang that compressed the multiple is gone."}, {"it": "Peer trade a 8.4x EV/EBITDA vs MATV 6.1x. Anche solo 7.5x sblocca +$5–7/sh.", "en": "Peers trade at 8.4x EV/EBITDA vs MATV 6.1x. Even a re-rate to 7.5x unlocks +$5–7/sh."} ], "bear_points": [ {"it": "Leva netta 3.8x ancora alta: ogni rallentamento macro colpisce l'equity prima dell'enterprise.", "en": "Net leverage 3.8x still elevated: any macro slowdown hits equity before enterprise."}, {"it": "Q3 2026 tornado Wisconsin: −$20–25M revenue confermato. Se peggio del previsto, momentum si ferma.", "en": "Q3 2026 Wisconsin tornado: −$20–25M revenue confirmed. If worse than expected, momentum stalls."}, {"it": "Interessi $37M H1 vicini all'operating profit: refinanziamento a spread più alti nel 2028 è un rischio reale.", "en": "Interest expense $37M H1 near operating profit line: 2028 refi at higher spreads is a real risk."} ], "risks": [ {"it": "Ciclicità input costs (pulp, energia, latex) può erodere il margine ritrovato in 2 trimestri.", "en": "Cyclical input cost exposure (pulp, energy, latex) could erode the freshly earned margin in 2 quarters."}, {"it": "Copertura sell-side limitata (1 analista): visibilità istituzionale bassa, sconto di illiquidità persistente.", "en": "Limited sell-side coverage (1 analyst): low institutional visibility, persistent illiquidity discount."}, {"it": "Commercial print in declino strutturale: sub-segmento SAS a −3/−5% l'anno, headwind cronico.", "en": "Commercial print in structural decline: SAS sub-segment at −3/−5%/year, chronic headwind."} ] }

Sources & Disclaimer

Sources: Mativ Q2 2026 earnings release (SEC 8-K, 2026-08-05), Q2 2026 earnings call transcript (Seeking Alpha, 2026-08-06), Q2 2026 10-Q, stockanalysis.com, Simply Wall St, Yahoo Finance (price data 2026-09-04 close), Investing.com (peer valuations), Stifel analyst PT $21 (Sep 2026), FY2025 full-year results (Mativ IR). Market data — last verified close 2026-09-04 ($12.52, T-1 trading days from report date). 52W range $7.07 – $15.48. ⚠️ Not investment advice. This document represents independent analysis for informational purposes only. It is not a solicitation, recommendation, or personalized investment advice. Consult a licensed financial advisor before making investment decisions. Data reflects publicly available information as of report date; conditions can change materially.